A Phase I/IIa Clinical Trial in Duchenne Muscular Dystrophy Using Systemically Delivered Morpholino Antisense Oligomer to Skip Exon 53 (SKIP-NMD)

Go down

A Phase I/IIa Clinical Trial in Duchenne Muscular Dystrophy Using Systemically Delivered Morpholino Antisense Oligomer to Skip Exon 53 (SKIP-NMD) Empty A Phase I/IIa Clinical Trial in Duchenne Muscular Dystrophy Using Systemically Delivered Morpholino Antisense Oligomer to Skip Exon 53 (SKIP-NMD)

Post  Jon Moulton on Mon Jun 22, 2015 10:21 am

No Authors Listed. A Phase I/IIa Clinical Trial in Duchenne Muscular Dystrophy Using Systemically Delivered Morpholino Antisense Oligomer to Skip Exon 53 (SKIP-NMD). Human Gene Therapy Clinical Development. June 2015, 26(2): 92-95. doi:10.1089/humc.2015.2528


Last edited by Jon Moulton on Mon Jun 22, 2015 10:22 am; edited 1 time in total (Reason for editing : Fix URL)
Jon Moulton
Jon Moulton

Posts : 5721
Join date : 2010-03-12
Age : 57
Location : Philomath, Oregon, USA

http://www.gene-tools.com

Back to top Go down

Back to top


 
Permissions in this forum:
You cannot reply to topics in this forum